VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Monday, December 29, 2025
Stock Comparison
Novo Nordisk A/S vs UiPath, Inc.
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Novo Nordisk A/S
NOVOB · Nasdaq Copenhagen
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Novo Nordisk A/S's moat claims, evidence, and risks.
View NOVOB analysisUiPath, Inc.
PATH · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into UiPath, Inc.'s moat claims, evidence, and risks.
View PATH analysisComparison highlights
- Moat score gap: Novo Nordisk A/S leads (85 / 100 vs 70 / 100 for UiPath, Inc.).
- Segment focus: Novo Nordisk A/S has 3 segments (71.1% in Diabetes care); UiPath, Inc. has 2 segments (97.2% in Automation Platform).
- Moat breadth: Novo Nordisk A/S has 5 moat types across 3 domains; UiPath, Inc. has 3 across 2.
Primary market context
Novo Nordisk A/S
Diabetes care
Diabetes pharmaceuticals (GLP-1 for type 2 diabetes, insulin, and related therapies)
Global
Payers/providers and patients (via wholesalers/pharmacies/hospitals)
Originator pharma (R&D, regulatory, manufacturing, commercialization)
71.1%
UiPath, Inc.
Automation Platform
Enterprise automation software (RPA + agentic automation platform)
Global
Enterprises and public sector
Software platform vendor
97.2%
Side-by-side metrics
Moat coverage
Shared moat types
No overlap yet.
Novo Nordisk A/S strengths
UiPath, Inc. strengths
Segment mix
Novo Nordisk A/S segments
Full profile >Diabetes care
Oligopoly
Obesity care
Duopoly
Rare disease
Oligopoly
UiPath, Inc. segments
Full profile >Automation Platform
Oligopoly
Professional Services and Enablement
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.